Mouri Akihiro, Lee Hsin-Jung, Mamiya Takayoshi, Aoyama Yuki, Matsumoto Yurie, Kubota Hisayoshi, Huang Wei-Jan, Chiou Lih-Chu, Nabeshima Toshitaka
Advanced Diagnostic System Research Laboratory, Fujita Health University, Graduate School of Health Sciences, Toyoake, Japan.
Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices, Fujita Health University, Graduate School of Health Sciences, Toyoake, Japan.
Br J Pharmacol. 2020 Jul;177(14):3210-3224. doi: 10.1111/bph.15043. Epub 2020 Apr 3.
Hispidulin is a flavonoid isolated from Clerodendrum inerme that was found to inhibit intractable motor tics. Previously, we found that hispidulin attenuates hyperlocomotion and the disrupted prepulse inhibition induced by methamphetamine and N-methyl-d-aspartate (NMDA) receptor antagonists, two phenotypes of schizophrenia resembling positive symptoms. Hispidulin can inhibit COMT, a dopamine-metabolizing enzyme in the prefrontal cortex (PFC) that is important for social interaction. Here, we investigated whether hispidulin would affect social withdrawal, one of the negative symptoms of schizophrenia.
We examined whether acute administration of hispidulin would attenuate social withdrawal in two mice models, juvenile isolated disrupted-in-schizophrenia-1 mutant (mutDISC1) mice and chronic phencyclidine (PCP)-treated naïve mice.
In chronic PCP-treated mice, hispidulin (10 mg·kg , i.p.) attenuated social withdrawal similar to that observed with dopamine D receptor antagonist (SCH-23390, 0.02 mg·kg , i.p.) and was mimicked by the selective COMT inhibitor, OR-486 (10 mg·kg , i.p.). Hispidulin increased extracellular dopamine levels in the PFC of chronic PCP-treated mice. In isolated mutDISC1 mice, hispidulin also reversed social withdrawal. In both models, intra-PFC microinjection of a D agonist (SKF-81297: 10 nmol/mouse/bilateral) reversed the impairment of Ser phosphorylation at the GluN1 subunit of NMDA receptors, suggesting the association between GluN1 Ser -phosphorylation and D activation in the PFC exits in both models.
Hispidulin attenuated social withdrawal by activating D receptors indirectly through elevated dopamine levels in the PFC by COMT inhibition. This nature of hispidulin suggests that it a potential novel therapeutic candidate for the treatment of negative symptoms in schizophrenia.
海胆苷是从假茉莉中分离出的一种黄酮类化合物,已发现其可抑制顽固性运动性抽动。此前,我们发现海胆苷可减轻由甲基苯丙胺和N - 甲基 - D - 天冬氨酸(NMDA)受体拮抗剂诱导的运动亢进及前脉冲抑制破坏,这两种精神分裂症的表型类似于阳性症状。海胆苷可抑制儿茶酚 - O - 甲基转移酶(COMT),这是前额叶皮质(PFC)中一种对社交互动很重要的多巴胺代谢酶。在此,我们研究了海胆苷是否会影响精神分裂症的阴性症状之一——社交退缩。
我们检测了急性给予海胆苷是否会减轻两种小鼠模型中的社交退缩,即幼年隔离的精神分裂症破坏 - 1突变体(mutDISC1)小鼠和慢性苯环己哌啶(PCP)处理的未处理小鼠。
在慢性PCP处理的小鼠中,海胆苷(10 mg·kg ,腹腔注射)减轻社交退缩的程度与多巴胺D受体拮抗剂(SCH - 23390,0.02 mg·kg ,腹腔注射)相似,且选择性COMT抑制剂OR - 486(10 mg·kg ,腹腔注射)可模拟其作用。海胆苷增加了慢性PCP处理小鼠PFC中的细胞外多巴胺水平。在隔离的mutDISC1小鼠中,海胆苷也逆转了社交退缩。在两种模型中,PFC内微量注射D激动剂(SKF - 81297:10 nmol/小鼠/双侧)逆转了NMDA受体GluN1亚基上Ser磷酸化的损伤,表明两种模型中PFC内GluN1 Ser磷酸化与D激活之间存在关联。
海胆苷通过抑制COMT提高PFC中的多巴胺水平,间接激活D受体,从而减轻社交退缩。海胆苷的这种特性表明它是治疗精神分裂症阴性症状的潜在新型治疗候选药物。